Gains May Be On The Menu For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $31.8 million. In addition, […]
Growing Through Challenges? – Coherus Biosciences Inc (CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Coherus Biosciences Inc (NASDAQ: CHRS) Hogging The Spotlight Today
With over 8.24 million Coherus Biosciences Inc (CHRS) shares trading Tuesday and a closing price of $2.18 on the day, the dollar volume was approximately $17.97 million. The shares have shown a negative half year performance of -43.23% and its price on 12/26/23 gained nearly 7.92%. Currently, there are 111.36M common shares owned by the […]
There Is Clear Momentum For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. has recently announced that it has increased stake in Coherus Biosciences Inc (NASDAQ:CHRS) by 4.89%. After grabbing 9.55 million shares, the institutional investor is now in possession of 0.44 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.58% having worth around $20.34 million. […]
